English
简体中文
Total: £ 56.28
Published Date: 2025-04-08 | Pages: 81 | Tables: 85 | Medical Care
The global market for Leukemia Molecular Diagnostics was valued at US$ 2115 million in the year 2024 and is projected to reach a revised size of US$ 4175 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Molecular diagnosis of leukemia is a method of diagnosing and classifying leukemia by detecting specific gene mutations, chromosomal abnormalities or other molecular markers in leukemia patients. This diagnostic technology uses advanced molecular biology tools such as PCR (polymerase chain reaction), gene sequencing and fluorescence in situ hybridization (FISH) to identify molecular features in leukemia cells. Molecular diagnosis of leukemia not only helps to diagnose the disease, but also can accurately classify leukemia subtypes, providing an important basis for the formulation of individualized treatment plans. This precise diagnostic method helps to assess the patient's prognosis, monitor the effectiveness of treatment, and detect the risk of recurrence at an early stage. It is an indispensable tool in modern leukemia management.
The increasing adoption of personalized medicine is a key driver for the leukemia molecular diagnostics market. Advances in molecular diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), enable precise genetic profiling of leukemia, leading to more targeted and effective treatment plans. This personalized approach not only improves patient outcomes but also boosts demand for molecular diagnostics in leukemia management.
One of the main challenges in the leukemia molecular diagnostics market is the high cost associated with advanced diagnostic tools and testing procedures. These technologies often require significant investment in equipment, skilled personnel, and infrastructure, which can limit accessibility in low-resource settings, reducing the potential reach of molecular diagnostics in leukemia care.
This report aims to provide a comprehensive presentation of the global market for Leukemia Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leukemia Molecular Diagnostics.
The Leukemia Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Leukemia Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leukemia Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ruiang Gene
Zhishan Bio
Zhijiang Bio
Jinpujia Medical
Merle Bio
Herui Gene
Aicon Bio
Annuouda
Beijing Wantai
Haixi Bio
Qiagen
Abbott
Kanglu Biotechnology
Guangzhou Anbiping
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Leukemia Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Leukemia Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Molecular Diagnostics Market Perspective (2020-2031)
2.2 Global Leukemia Molecular Diagnostics Growth Trends by Region
2.2.1 Global Leukemia Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Leukemia Molecular Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Leukemia Molecular Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Leukemia Molecular Diagnostics Market Dynamics
2.3.1 Leukemia Molecular Diagnostics Industry Trends
2.3.2 Leukemia Molecular Diagnostics Market Drivers
2.3.3 Leukemia Molecular Diagnostics Market Challenges
2.3.4 Leukemia Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Molecular Diagnostics Players by Revenue
3.1.1 Global Top Leukemia Molecular Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Leukemia Molecular Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Leukemia Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Leukemia Molecular Diagnostics Revenue
3.4 Global Leukemia Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Leukemia Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Molecular Diagnostics Revenue in 2024
3.5 Global Key Players of Leukemia Molecular Diagnostics Head office and Area Served
3.6 Global Key Players of Leukemia Molecular Diagnostics, Product and Application
3.7 Global Key Players of Leukemia Molecular Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leukemia Molecular Diagnostics Breakdown Data by Type
4.1 Global Leukemia Molecular Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Leukemia Molecular Diagnostics Forecasted Market Size by Type (2026-2031)
5 Leukemia Molecular Diagnostics Breakdown Data by Application
5.1 Global Leukemia Molecular Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Leukemia Molecular Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Leukemia Molecular Diagnostics Market Size (2020-2031)
6.2 North America Leukemia Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Leukemia Molecular Diagnostics Market Size by Country (2020-2025)
6.4 North America Leukemia Molecular Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Molecular Diagnostics Market Size (2020-2031)
7.2 Europe Leukemia Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Leukemia Molecular Diagnostics Market Size by Country (2020-2025)
7.4 Europe Leukemia Molecular Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Molecular Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Leukemia Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Leukemia Molecular Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Leukemia Molecular Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Leukemia Molecular Diagnostics Market Size (2020-2031)
9.2 Latin America Leukemia Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Leukemia Molecular Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Leukemia Molecular Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Molecular Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Leukemia Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Leukemia Molecular Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Leukemia Molecular Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ruiang Gene
11.1.1 Ruiang Gene Company Details
11.1.2 Ruiang Gene Business Overview
11.1.3 Ruiang Gene Leukemia Molecular Diagnostics Introduction
11.1.4 Ruiang Gene Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.1.5 Ruiang Gene Recent Development
11.2 Zhishan Bio
11.2.1 Zhishan Bio Company Details
11.2.2 Zhishan Bio Business Overview
11.2.3 Zhishan Bio Leukemia Molecular Diagnostics Introduction
11.2.4 Zhishan Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.2.5 Zhishan Bio Recent Development
11.3 Zhijiang Bio
11.3.1 Zhijiang Bio Company Details
11.3.2 Zhijiang Bio Business Overview
11.3.3 Zhijiang Bio Leukemia Molecular Diagnostics Introduction
11.3.4 Zhijiang Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.3.5 Zhijiang Bio Recent Development
11.4 Jinpujia Medical
11.4.1 Jinpujia Medical Company Details
11.4.2 Jinpujia Medical Business Overview
11.4.3 Jinpujia Medical Leukemia Molecular Diagnostics Introduction
11.4.4 Jinpujia Medical Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.4.5 Jinpujia Medical Recent Development
11.5 Merle Bio
11.5.1 Merle Bio Company Details
11.5.2 Merle Bio Business Overview
11.5.3 Merle Bio Leukemia Molecular Diagnostics Introduction
11.5.4 Merle Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.5.5 Merle Bio Recent Development
11.6 Herui Gene
11.6.1 Herui Gene Company Details
11.6.2 Herui Gene Business Overview
11.6.3 Herui Gene Leukemia Molecular Diagnostics Introduction
11.6.4 Herui Gene Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.6.5 Herui Gene Recent Development
11.7 Aicon Bio
11.7.1 Aicon Bio Company Details
11.7.2 Aicon Bio Business Overview
11.7.3 Aicon Bio Leukemia Molecular Diagnostics Introduction
11.7.4 Aicon Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.7.5 Aicon Bio Recent Development
11.8 Annuouda
11.8.1 Annuouda Company Details
11.8.2 Annuouda Business Overview
11.8.3 Annuouda Leukemia Molecular Diagnostics Introduction
11.8.4 Annuouda Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.8.5 Annuouda Recent Development
11.9 Beijing Wantai
11.9.1 Beijing Wantai Company Details
11.9.2 Beijing Wantai Business Overview
11.9.3 Beijing Wantai Leukemia Molecular Diagnostics Introduction
11.9.4 Beijing Wantai Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.9.5 Beijing Wantai Recent Development
11.10 Haixi Bio
11.10.1 Haixi Bio Company Details
11.10.2 Haixi Bio Business Overview
11.10.3 Haixi Bio Leukemia Molecular Diagnostics Introduction
11.10.4 Haixi Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.10.5 Haixi Bio Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Leukemia Molecular Diagnostics Introduction
11.11.4 Qiagen Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.11.5 Qiagen Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Leukemia Molecular Diagnostics Introduction
11.12.4 Abbott Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.12.5 Abbott Recent Development
11.13 Kanglu Biotechnology
11.13.1 Kanglu Biotechnology Company Details
11.13.2 Kanglu Biotechnology Business Overview
11.13.3 Kanglu Biotechnology Leukemia Molecular Diagnostics Introduction
11.13.4 Kanglu Biotechnology Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.13.5 Kanglu Biotechnology Recent Development
11.14 Guangzhou Anbiping
11.14.1 Guangzhou Anbiping Company Details
11.14.2 Guangzhou Anbiping Business Overview
11.14.3 Guangzhou Anbiping Leukemia Molecular Diagnostics Introduction
11.14.4 Guangzhou Anbiping Revenue in Leukemia Molecular Diagnostics Business (2020-2025)
11.14.5 Guangzhou Anbiping Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Leukemia Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Leukemia Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Leukemia Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Leukemia Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Leukemia Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Leukemia Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Leukemia Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Leukemia Molecular Diagnostics Market Trends
Table 13. Leukemia Molecular Diagnostics Market Drivers
Table 14. Leukemia Molecular Diagnostics Market Challenges
Table 15. Leukemia Molecular Diagnostics Market Restraints
Table 16. Global Leukemia Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Leukemia Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Leukemia Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Leukemia Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Leukemia Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Leukemia Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Leukemia Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Leukemia Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Leukemia Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Leukemia Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Leukemia Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Leukemia Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Leukemia Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Leukemia Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Leukemia Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Leukemia Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Leukemia Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Leukemia Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Leukemia Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Leukemia Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Leukemia Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Leukemia Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Leukemia Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Leukemia Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Leukemia Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Leukemia Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Leukemia Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Leukemia Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Leukemia Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Leukemia Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Leukemia Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Ruiang Gene Company Details
Table 49. Ruiang Gene Business Overview
Table 50. Ruiang Gene Leukemia Molecular Diagnostics Product
Table 51. Ruiang Gene Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Ruiang Gene Recent Development
Table 53. Zhishan Bio Company Details
Table 54. Zhishan Bio Business Overview
Table 55. Zhishan Bio Leukemia Molecular Diagnostics Product
Table 56. Zhishan Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Zhishan Bio Recent Development
Table 58. Zhijiang Bio Company Details
Table 59. Zhijiang Bio Business Overview
Table 60. Zhijiang Bio Leukemia Molecular Diagnostics Product
Table 61. Zhijiang Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Zhijiang Bio Recent Development
Table 63. Jinpujia Medical Company Details
Table 64. Jinpujia Medical Business Overview
Table 65. Jinpujia Medical Leukemia Molecular Diagnostics Product
Table 66. Jinpujia Medical Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 67. Jinpujia Medical Recent Development
Table 68. Merle Bio Company Details
Table 69. Merle Bio Business Overview
Table 70. Merle Bio Leukemia Molecular Diagnostics Product
Table 71. Merle Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 72. Merle Bio Recent Development
Table 73. Herui Gene Company Details
Table 74. Herui Gene Business Overview
Table 75. Herui Gene Leukemia Molecular Diagnostics Product
Table 76. Herui Gene Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 77. Herui Gene Recent Development
Table 78. Aicon Bio Company Details
Table 79. Aicon Bio Business Overview
Table 80. Aicon Bio Leukemia Molecular Diagnostics Product
Table 81. Aicon Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 82. Aicon Bio Recent Development
Table 83. Annuouda Company Details
Table 84. Annuouda Business Overview
Table 85. Annuouda Leukemia Molecular Diagnostics Product
Table 86. Annuouda Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 87. Annuouda Recent Development
Table 88. Beijing Wantai Company Details
Table 89. Beijing Wantai Business Overview
Table 90. Beijing Wantai Leukemia Molecular Diagnostics Product
Table 91. Beijing Wantai Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 92. Beijing Wantai Recent Development
Table 93. Haixi Bio Company Details
Table 94. Haixi Bio Business Overview
Table 95. Haixi Bio Leukemia Molecular Diagnostics Product
Table 96. Haixi Bio Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 97. Haixi Bio Recent Development
Table 98. Qiagen Company Details
Table 99. Qiagen Business Overview
Table 100. Qiagen Leukemia Molecular Diagnostics Product
Table 101. Qiagen Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. Abbott Company Details
Table 104. Abbott Business Overview
Table 105. Abbott Leukemia Molecular Diagnostics Product
Table 106. Abbott Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 107. Abbott Recent Development
Table 108. Kanglu Biotechnology Company Details
Table 109. Kanglu Biotechnology Business Overview
Table 110. Kanglu Biotechnology Leukemia Molecular Diagnostics Product
Table 111. Kanglu Biotechnology Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 112. Kanglu Biotechnology Recent Development
Table 113. Guangzhou Anbiping Company Details
Table 114. Guangzhou Anbiping Business Overview
Table 115. Guangzhou Anbiping Leukemia Molecular Diagnostics Product
Table 116. Guangzhou Anbiping Revenue in Leukemia Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 117. Guangzhou Anbiping Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Leukemia Molecular Diagnostics Picture
Figure 2. Global Leukemia Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Leukemia Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Leukemia Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Leukemia Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Leukemia Molecular Diagnostics Report Years Considered
Figure 14. Global Leukemia Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Leukemia Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Leukemia Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Leukemia Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Leukemia Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukemia Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Leukemia Molecular Diagnostics Revenue in 2024
Figure 20. North America Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Leukemia Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Leukemia Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Leukemia Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Leukemia Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Leukemia Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Leukemia Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Ruiang Gene Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 50. Zhishan Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 51. Zhijiang Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 52. Jinpujia Medical Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 53. Merle Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 54. Herui Gene Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 55. Aicon Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 56. Annuouda Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 57. Beijing Wantai Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 58. Haixi Bio Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 59. Qiagen Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 60. Abbott Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 61. Kanglu Biotechnology Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 62. Guangzhou Anbiping Revenue Growth Rate in Leukemia Molecular Diagnostics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
